AdaptX (fka MDmetrix), a Seattle, WA-based clinical performance management solution company, closed a $6m Series A funding.
The round was led by Vulcan Capital with participation from existing investors Founders’ Co-op, Arnold Venture Group, WRF Capital, and Alumni Ventures Group.
The company will use these new funds to add key hires and to invest in its adaptive clinical management technology.
Founded in 2016 and led by Warren Ratliff, chief executive officer, and Dan Low, MD, associate professor at the University of Washington and chief medical officer, AdaptX provides an Adaptive Clinical Management™ solution, which allows health systems to tackle the biggest issues including recovery from the Covid-19 financial crisis, quality of care, health equity, and value-based payments. Its AI-driven Mission Control Center empowers clinical leaders to leverage their real-world data to visualize performance, compare approaches, and ADAPT – across patients, teams, protocols, workflows, and facilities.